Onconova Therapeutics announces $16.5M share purchase agreement with Lincoln Park Capital
Onconova Therapeutics announced a share purchase agreement with Lincoln Park Capital Fund. LPC made an initial purchase of 846,755 shares of the Company's common stock for $1,500,000. LPC is obligated to purchase, up to an additional $15,000,000 in amounts of shares of the Company's common stock. October 08, 2015